TL;DR: A new study (Fang et al., 2025) in the Journal of Translational Medicine reports that epicatechin, a flavanol found in green tea, cocoa and fruit, reduced the stem-cell-like properties of liver cancer cells and tumor growth in mice. It did so by restoring DNA methylation of the GINS1 gene promoter, which dampened the GINS1/HRAS pathway. These are cell and mouse data; no human trials exist yet.
Table of Contents
Quick answer
In a 2025 laboratory and mouse study, the plant compound epicatechin lowered the stem-cell-like properties of liver cancer cells by restoring DNA methylation of the GINS1 gene. This is preclinical research: there is no evidence yet that epicatechin from food or supplements affects liver cancer in people, and it is not a treatment.
What is Epicatechin?
Epicatechin belongs to the flavanols, a subclass of polyphenols that occur as secondary plant compounds in numerous foods. Chemically, it is a diastereomer of catechin with cis-configuration. The most common form in nature is (−)-epicatechin.
Definition: Epicatechin (EC) is a plant-based flavanol from the polyphenol family. It is described in the literature as having antioxidant and anti-inflammatory properties in laboratory settings, like other plant pigments such as astaxanthin (German). It naturally occurs in green tea, cocoa, dark grapes, apples, and berries and is increasingly studied in biomedical research as a bioactive compound, including for possible anti-cancer mechanisms in cell and animal models.
The richest natural sources of epicatechin are unprocessed cocoa powder (values of up to roughly 200 mg per 100 g are reported, depending on the product), green tea, dark grapes, apples (especially the skin), and berries. The processing method is crucial for the epicatechin content: heavy heating or "Dutch processing" (alkalizing) of cocoa can significantly reduce flavanol levels. Green tea, brewed gently at a maximum of 85°C (185°F), preserves its catechin content much better.
When epicatechin is ingested through food, it is partially absorbed in the small intestine and subsequently metabolized in the intestinal wall and liver. The main metabolites are glucuronidated and sulfated derivatives. The portion not absorbed in the small intestine is further broken down by gut flora in the colon. That matters for in vitro studies: cells in a dish meet the original compound, while human tissue mostly sees its metabolites.
New Study 2025: Epicatechin Against Liver Cancer Stem Cells
In July 2025, Fang et al. published a paper in the Journal of Translational Medicine describing a previously unreported mechanism by which epicatechin reduced the growth of liver cancer cells in the lab. The study connects several levels, from epigenetic regulation and protein-protein interactions to mouse experiments, and gives a detailed mechanistic picture of epicatechin's effect in hepatocellular carcinoma (HCC) models.
Fang et al. (2025) at a glance
- Cells + miceStudy models: liver cancer cell lines (mainly HepG2) and xenograft tumors in mice
- GINS1Oncogene whose promoter methylation epicatechin restored
- HRASOncoprotein that GINS1 binds and activates
- 0Human trials on this mechanism so far
Hepatocellular Carcinoma: Few Treatment Options
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, characterized by high malignancy and rapid progression. According to WHO/IARC projections, liver cancer deaths could exceed one million per year by 2030. Despite advances in surgery, chemotherapy, and immunotherapy, therapeutic options remain limited, partly because of a subpopulation of highly resistant cells: Liver Cancer Stem Cells (LCSCs).
What are Cancer Stem Cells?
Cancer Stem Cells (CSCs) possess the ability to self-renew and proliferate indefinitely. In the context of HCC, LCSCs play a central role in tumor initiation, distant metastasis, and chemotherapy resistance. Their existence is a major reason why liver tumors can recur after seemingly successful treatment. That is why researchers look for strategies that target LCSCs specifically.
GINS1: An Oncogene in Focus
The researchers identified the gene GINS1 (Go-Ichi-Ni-San Complex Subunit 1) as a key player. GINS1 is part of the GINS complex, which is essential for DNA replication and rapid cell division. Using TCGA (The Cancer Genome Atlas) database analyses, the authors demonstrated that GINS1 is significantly overexpressed in HCC tissues and correlates with a poorer overall survival rate.
The Mechanism: Epigenetic Silencing via DNA Methylation
The core of the study is the mechanism: The researchers showed that the promoter region of GINS1 is hypomethylated in liver cancer cells: it carries fewer methyl groups than in normal liver cells. This reduced methylation allows for excessive GINS1 expression. Changes in DNA methylation are also one of the 12 hallmarks of aging (German). The methyl groups themselves come from the methionine cycle, which depends on folate and vitamin B12, as our article on B vitamins and methylation (German) explains.
Treatment with epicatechin restored the DNA methylation of the GINS1 promoter, thereby lowering GINS1 expression. This effect was reversed by the methylation inhibitor 5-Azacytidine (5-Aza), a strong indication that the mechanism indeed operates via the epigenetic level of DNA methylation.
The GINS1-HRAS Pathway
The study went a step further: GINS1 physically interacts with the oncoprotein HRAS and activates it. HRAS is a known driver of carcinogenesis. Overexpression of HRAS was able to partially reverse the inhibitory effects of GINS1 silencing, and also the anti-tumor effects of epicatechin.
The proposed pathway in five steps (Fang et al., 2025, cells and mice)
- Epicatechin is given to liver cancer cells or to mice with xenograft tumors.
- DNA methylation of the GINS1 promoter increases again.
- The cells produce less GINS1.
- Less GINS1 means less activation of the oncoprotein HRAS.
- Stem-cell-like properties and tumor growth decrease.
The 6 Key Findings (Fang et al., 2025)
- GINS1 is overexpressed in liver cancer cells and specifically in liver cancer stem cells.
- Silencing GINS1 inhibits migration, invasion, and stem cell properties of HCC cells.
- Epicatechin restores DNA methylation of the GINS1 promoter, lowering GINS1 expression.
- GINS1 physically interacts with the oncoprotein HRAS, activating it.
- HRAS overexpression partially nullifies the tumor-suppressive effects of epicatechin.
- In mouse models, epicatechin significantly reduced tumor growth via this pathway.
Earlier Lab Studies on Other Cancers
The study by Fang et al. builds on a growing field of research. Epicatechin and related catechins have been investigated in cell and animal models for years. None of these findings has been confirmed in human trials.
- Lung Cancer: Lv et al. (2024, PLOS ONE) reported that epicatechin promoted ferroptosis (iron-dependent cell death) in lung cancer cells. Another study reported that it may increase radiosensitivity of lung cancer cells in the lab.
- Breast Cancer: In cell experiments, epicatechin acted as an agonist of the membrane androgen receptor ZIP9, which was linked to apoptosis in breast cancer cells.
- Colon Cancer: Investigations with epicatechin gallate (ECG) have reported impaired tumor metabolism and a slowed pentose phosphate pathway in cell models.
Epicatechin Beyond Cancer Research
Biomedical research on epicatechin is not limited to oncology. Several other areas are being studied; most of the evidence is preliminary:
-
Cardiovascular system
Cocoa flavanols, including epicatechin, have been linked to endothelial function and nitric oxide (NO) production in small human studies. Observational work on the Kuna population in Panama points to an association between high cocoa intake and cardiovascular health, which does not prove cause and effect. -
Metabolism
Some studies report effects on insulin sensitivity and the HOMA-IR index; results are mixed. -
Brain
Preclinical models suggest possible effects on nerve cells and cerebral blood flow. -
Muscle & training
In fitness circles, epicatechin is discussed for a possible influence on the myostatin/follistatin ratio; our myostatin guide explains what the evidence does and does not show.
About green tea extracts
Green tea is one of the most common everyday sources of catechins. If you prefer it in tablet form, AYUBA Green Tea Premium provides 100 mg extract with 40 % polyphenols (40 mg) and 8 mg natural caffeine per daily dose of 2 tablets, made in Germany and tested in an independent laboratory. It is a food supplement for healthy adults and was not part of the study described above.
Scientific Context & Limitations
As promising as the results from Fang et al. are, an honest scientific assessment is essential.
| Criterion | Status of Fang Study (2025) | Missing for Clinical Relevance |
|---|---|---|
| Study Type | In vitro (Cells) + In vivo (Mice) | Randomized Human Trials |
| Cancer Type | HCC (Hepatocellular Carcinoma) | Transferability to other cancers |
| Bioavailability | Not separately analyzed | Pharmacokinetics in humans |
The authors themselves emphasize limitations: The experiments were primarily conducted on HepG2 cells and mice. It remains unclear whether orally ingested epicatechin can reach sufficient concentrations at the target site in humans to achieve these epigenetic effects.
Conclusion: A Mechanism, Not a Treatment
The study by Fang et al. (2025) offers detailed mechanistic insight into how epicatechin acted on liver cancer cells and mice in the lab. Identifying the EC → DNA methylation → GINS1 → HRAS pathway is scientifically interesting because it goes beyond the general antioxidant rationale (see our German article on oxidative stress) and describes a concrete, epigenetic mechanism.
From a scientific perspective, the logical next step is to investigate bioavailability and efficacy in clinical pilot studies, potentially in combination with existing therapies.
Frequently asked questions
Can Epicatechin cure cancer?
No. Current data comes from cell culture and animal studies. There are currently no clinical studies proving the efficacy of epicatechin as a cancer therapy in humans. It is not a medication.
Is Epicatechin the same as EGCG?
No. Epicatechin (EC) and Epigallocatechin Gallate (EGCG) are both catechins found in green tea, but they differ in chemical structure and profile. EGCG has been studied more widely in cancer research.
How much Epicatechin should one take?
There is no official recommendation, because epicatechin is not an essential nutrient. Studies on vascular function used standardized cocoa-flavanol extracts, but the concentrations used in cancer cell experiments cannot be transferred to food or supplement intake. Do not use supplements to try to treat cancer; talk to your doctor.
Which foods are richest in epicatechin?
Unprocessed cocoa powder leads the list, with values of up to roughly 200 mg per 100 g reported depending on the product. Green tea, dark grapes, apples with their skin and berries follow. Non-alkalized cocoa and gently brewed green tea keep the most flavanols.
Does epicatechin from food reach the liver?
Yes, but mostly in modified form. Epicatechin is partly absorbed in the small intestine and then converted in the intestinal wall and liver into glucuronidated and sulfated metabolites. Cell experiments like those in the Fang study use the original compound, which is one reason why the results cannot be transferred directly to people.
References
- Fang X, Cai Y, Peng X, Li Z, Huang M, Li Y, Liu P. Epicatechin attenuates the stemness of liver cancer stem cells and tumorigenesis through DNA methylation-mediated inactivation of GINS1/HRAS. Journal of Translational Medicine. 2025;23:828.
- Lv Z, Liu P, Yang Y et al. (−)-Epicatechin regulates endoplasmic reticulum stress and promotes ferroptosis in lung cancer cells. PLOS ONE. 2024;19(10):e0313010.
- Downregulation of MMP-9 by epicatechin can improve the radiosensitivity of non-small cell lung cancer. Journal of Cancer Research and Therapeutics. 2024;20(4):1284–1292.
- Thomas P, Dong J. (−)-Epicatechin acts as a potent agonist of the membrane androgen receptor, ZIP9. J Steroid Biochem Mol Biol. 2021;211:105906.
Medical Disclaimer: This article is for informational purposes only and does not replace medical advice, diagnosis, or treatment. The results described are from preclinical models. Supplements are not a substitute for a balanced diet. Consult a healthcare professional for medical concerns.
Ayuba Langer
Founder & Head of Copywriting at Ayuba Nutrition. Specializing in evidence-based health communication and scientific content marketing in the supplement sector.
Last verified: October 2026